ACTIVE_NOT_RECRUITING

Mobile CARE-App to Promote Coping for Caregivers of Patients Receiving Stem Cell Transplant

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this research study is to determine whether a self-administered, psychosocial mobile application (CARE app) is effective at improving the quality of life and experience of caregivers of patients receiving hematopoietic stem cell transplantation (HCT).

Official Title

Randomized Controlled Trial of a Psychosocial Mobile Application (App) to Promote Coping for Caregivers of Patients Receiving Hematopoietic Cell Transplantation (HCT)

Quick Facts

Study Start:2023-07-01
Study Completion:2026-12-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT05709912

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adult caregivers (\>18 years) who is a relative or friend who live with the patient or is a designated caregiver as indicated during the transplant process.
  2. * Caregiver of a patient receiving allogeneic or autologous HCT for the treatment of cancer
  3. * Ability to comprehend and speak English as the CARE app is only available in English
  1. * Caregivers of patients undergoing HCT for benign hematologic conditions
  2. * Caregivers with acute or unstable psychiatric or cognitive conditions which the treating clinicians believes prohibits informed consent or compliance with study procedures

Contacts and Locations

Principal Investigator

Areej El-Jawahri, MD
PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital

Study Locations (Sites)

Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02215
United States

Collaborators and Investigators

Sponsor: Massachusetts General Hospital

  • Areej El-Jawahri, MD, PRINCIPAL_INVESTIGATOR, Massachusetts General Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-07-01
Study Completion Date2026-12-01

Study Record Updates

Study Start Date2023-07-01
Study Completion Date2026-12-01

Terms related to this study

Keywords Provided by Researchers

  • Cognitive Behavioral Therapy
  • CBT
  • Hematopoietic stem cell transplantation
  • HCT
  • Bone Marrow Transplant Complications
  • Hematologic Malignancy

Additional Relevant MeSH Terms

  • Bone Marrow Transplant Complications
  • Hematologic Malignancy